CIDRAP newsletters options
Omicron was tied to a lower risk of maternal critical care (0.3% vs 1.8%) and preterm birth (1.8% vs 4.2%).
A simulated client study in Ethiopia found a high rate of non-prescription antibiotic dispensing at community pharmacies, researchers reported today in the Journal of Antimicrobial Chemotherapy.
A US study of almost 17,000 patients finds modest two-dose Pfizer COVID vaccine effectiveness (VE) against hospitalization and emergency department (ED) admission for Omicron BA.1 (the original Omicron variant) and the BA.2 subvariant, but three-dose VE was 79% and 71% for hospitalization, respectively, and 72% and 21% for ED visits.
Teens reported low physical activity, poor quality of life, and high rates of anxiety and depression in 2020.
COVID activity continued to rise in many European countries last week, up 14% compared to the previous week, in people ages 65 and older, the European Centre for Disease Prevention and Control (ECDC) said today in a regular update.
In the United States, COVID indicators continue to fall, with the BA.5 Omicron variant still dominant, but newer subvariants are slowly making more of a mark.
The results of a randomized clinical trial in Slovenia suggest that a 7-day course of antibiotics for a rash caused by Lyme disease is noninferior to a 14-day course, researchers reported yesterday in The Lancet Infectious Diseases.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Children who had an underlying illness were at greatest risk for severe COVID-19 and death, but those who were vaccinated were fairly well protected, according to an observational study presented this week at the American Academy of Pediatrics (AAP) National Conference & Exhibition in Anaheim, California.
Protection from earlier pre Omicron infection was modest, but strong from earlier Omicron infection.
Disparities still persist in disease burden, as well as monkeypox vaccine reach.
In a phase 3 trial, cefepime/enmetazobactam was noninferior to piperacillin/tazobactam for treating complicated urinary tract infections.
The US Centers for Disease Control and Prevention (CDC) urged clinicians to consider Ebola and other viral hemorrhagic fever illness in the workup of people who have symptoms of the diseases and to immediately take a travel history with an eye toward identifying those who have been in parts of Uganda affected by the recent Ebola Sudan outbreak.
So far 63 cases have been reported, including 29 deaths, and 10 healthcare workers have been infected.
Funds will target drugs against gram-positive pathogens, vaccines for neonatal sepsis, and weapons against gonorrhea.
The survey also found that about a third feel confident about getting the flu shot and COVID booster at the same time.
People living in states with more complex guidelines were less likely to correctly indicate their eligibility.
In its latest weekly update on the pandemic, the World Health Organization (WHO) said today that global COVID-19 cases declined 6% last week compared to the previous week, though the pace of activity increased in the European region, which experienced an 8% rise compared to the week before.
Venatorx Pharmaceuticals announced this week that it has received a contract from the US Department of Health and Human Services (HHS) Biomedical Advanced Research and Development Authority (BARDA) to develop the combination antibiotic cefipime-taniborbactam for treatment of melioidosis.
Vaccination was tied to a 12% lower risk of NICU care, 27% lower rate of stillbirth, and 54% lower odds of maternal COVID-19.
New statistics from Ohio and Florida published by the National Bureau of Economic Research (NBER) show that Republicans have suffered more COVID-related excess deaths than Democrats, adding to the literature that demonstrates the link between political party affiliation, vaccination uptake, and COVID-19 mortality.
